Abstract
In southern Brazil, the incidence of adrenocortical tumors is about 10-12 times higher than in the rest of the world, with prevalence of pediatric type due to the occurrence of a germline mutation in p53. Progress in understanding the biology of adrenocortical tumors is still incomplete, and most of the molecular markers used in the study are cell cycle regulators genes. AP-1 (activator p…